Hepatocellular adenoma is a heterogeneous group of benign neoplasms arising from hepatocellular cells and can be subclassified into four major groups based on genotypic and phenotypic characteristics. These four subtypes are hepatocyte nuclear factor (HNF) 1α-inactivated, β-catenin-activated, inflammatory, and unclassified adenomas. Immunohistochemistry studies have demonstrated that since β-catenin-activated adenomas have a higher risk of malignant transformation, the identification of the subtype of adenoma remains crucial in patient management. However, malignant transformation of hepatic adenoma without β-catenin overexpression can be seen in 30-65% cases. We report a case of malignant transformation of hepatic adenoma without overexpression of β-catenin in a 31-year-old man with a known glycogen storage disease (GSD) Type-1a, which was diagnosed on surveillance magnetic resonance imaging (MRI). The MRI showed a mild interval increase in one lesion with relative stability of the other adenomas. The lesion was presumed to be suspicious for a hepatocellular carcinoma (HCC) and was confirmed on pathology.
Joan Saldarriaga, Bettina Bisig, Gabrielle Couchy, Claire Castain, Jessica Zucman-Rossi, Charles Balabaud, Christine Sempoux and Paulette Bioulac-Sage (2017) Focal β-catenin mutation identified on formalin-fixed and paraffin-embedded inflammatory hepatocellular adenomas. Histopathology71(6):989. doi: 10.1111/his.13283
Lauren R Waskowicz, Jin Zhou, Dustin J Landau, Elizabeth D Brooks, Andrea Lim, Zollie A Yavarow, Tsubasa Kudo, Haoyue Zhang, Yajun Wu, Stuart Grant, Sarah P Young, Bay Boon Huat, Paul M Yen and Dwight D Koeberl (2018) Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia. :. doi: 10.1093/hmg/ddy343
Elizabeth D. Brooks, Dustin J. Landau, Jeffrey I. Everitt, Talmage T. Brown, Kylie M. Grady, Lauren Waskowicz, Cameron R. Bass, John D'Angelo, Yohannes G. Asfaw, Kyha Williams, Priya S. Kishnani and Dwight D. Koeberl (2018) Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy. J Inherit Metab Dis41(6):965. doi: 10.1007/s10545-018-0223-y
Xue-Yin Shen, Xu-Guang Hu, Young-Bae Kim, Mi-Na Kim, Sung-Yeon Hong, Bong-Wan Kim and Hee-Jung Wang (2019) Molecular classification of hepatocellular adenoma: A single-center experience. Ann Hepatobiliary Pancreat Surg23(2):109. doi: 10.14701/ahbps.2019.23.2.109
Branko Cuglievan, Brian A. Menegaz, April DePombo, Ajaykumar C. Morani, Roberto N. Miranda and Michael Rytting (2017) A pediatric patient with glycogen storage disease type IA and Castleman disease. Pediatr Blood Cancer64(8):e26431. doi: 10.1002/pbc.26431
Janardhana Ponnatapura, Ania Kielar, Lauren M.B. Burke, Mark E. Lockhart, Abdul-Rahman Abualruz, Rafel Tappouni and Neeraj Lalwani (2019) Hepatic complications of oral contraceptive pills and estrogen on MRI: Controversies and update - Adenoma and beyond. Magnetic Resonance Imaging60:110. doi: 10.1016/j.mri.2019.04.010
Jennifer Pogoriler, Allison F O’Neill, Stephan D Voss, Robert C Shamberger and Antonio R Perez-Atayde (2018) Hepatocellular Carcinoma in Fanconi-Bickel Syndrome. Pediatr Dev Pathol21(1):84. doi: 10.1177/1093526617693540
This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.